FDA WARNING_LETTER_RESPONSE - Barclay, Luke, & Pillai Specialty Pharmacy, PLLC - March 15, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Barclay, Luke, & Pillai Specialty Pharmacy, PLLC

Record Details

This WARNING LETTER RESPONSE record concerns Barclay, Luke, & Pillai Specialty Pharmacy, PLLC, with an inspection on March 15, 2024, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
Inspection Date: March 15, 2024
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Steven E. Porter (Program Division Director)
Sean M. Barclay

Open in Dashboard

ID · 72640080-8a37-4348-a61c-ca09198f80c8